More News

28 Aug 2007 Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
28 Aug 2007 Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
26 Aug 2007 Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
25 Aug 2007 Teva announces approval of generic Famvir(R) Tablets
25 Aug 2007 Phylogica enters anti-microbial field
24 Aug 2007 Company Implements Leadership Succession Plan
24 Aug 2007 Gene Logic establishes agreement with Merck Serono to discover new development paths for multiple clinical-stage drug candidates
23 Aug 2007 Enrollment begins on human PK study for Medidur(TM) FA
23 Aug 2007 Pfizer names Frank A. D'Amelio Chief Financial Officer
23 Aug 2007 Med Discovery and DRAXIMAGE establish research collaboration
23 Aug 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
23 Aug 2007 Actavis receives approval of Fentanyl Transdermal System in the US
22 Aug 2007 BioMarin licenses technology from leading cystic fibrosis research laboratory at the University of California, San Francisco
22 Aug 2007 Abraxis BioScience and The Scripps Research Institute Enter Exclusive Licensing Agreement for the Worldwide Development and Commercialization of a Novel Epothilone Therapeutic for the Treatment of Cancer
22 Aug 2007 Daiichi Sankyo and Forest Laboratories sign Letter of Intent for co-promotion of AZOR(TM)
22 Aug 2007 Watson receives FDA approval for generic Duragesic(R)
21 Aug 2007 Ranbaxy receives US FDA approval to manufacture and market Hydrocodone Bitartrate and Acetaminophen tablets USP
21 Aug 2007 Biopartners submits its novel interferon beta-1a, Biferonex(R), to the EMEA
21 Aug 2007 Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy
21 Aug 2007 Pharmion and MethylGene announce collaboration to develop sirtuin inhibitors as anti-cancer agents
21 Aug 2007 IsoTis receives FDA clearance for Accell Family of Products
20 Aug 2007 PDL BioPharma announces internal CEO investigation found no credible evidence of improper personal conduct or breach of fiduciary duty
17 Aug 2007 Inovio Biomedical partner Tripep receives approval to initiate Phase I/II study of novel vaccine for hepatitis C virus
17 Aug 2007 NEOPHARM presents updated development projections for its drug candidates at Annual Shareholder Meeting
17 Aug 2007 Cell Therapeutics, Inc. (CTI) enters agreement to acquire lymphoma drug Zevalin(R) from Biogen Idec for sales and marketing in the United States

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up